Benzodiazepines in Akathisia Case Management: Restlessness Was Not Simply Anxiety

Two case reports describe akathisia during complex drug regimens and use of several symptom-directed treatments.

The diagnostic context

Patients developed restlessness, tremor, insomnia, and other complaints after additional medicines were introduced to existing psychotropic regimens. The authors used clinical classification and the Barnes scale to identify akathisia. Management included medication changes and combinations of anticholinergics, benzodiazepines, and beta blockers.

Neither interaction nor treatment effect was isolated

The cases suggest possible drug-interaction contributions but do not provide controlled exposure or pharmacokinetic proof. Improvement cannot be assigned independently to the benzodiazepine component. The important distinction for review is that visible restlessness can have a medication-induced movement-disorder explanation, rather than representing only recurrent psychiatric illness. Document the subjective urge to move, objective signs, new medicines, and timing. The report does not establish a universal rescue regimen or prove that every symptom after a prescription change reflects akathisia.

Source paper

Original analysis of the supplied journal article, identified as PMC7196143.

Related research

• Remimazolam Anxiety Dose-Finding Study Used a Specific Parent-Separation Endpoint
• Suicide Autopsy Series Found Benzodiazepines Across Different Death Mechanisms